Re:'An explosion': what's behind a rise in girls questioning...
by salawat on Friday November 25, 2022 @02:39PM
(#33746016)
They already have that with
...most patients.
Didn't you read the Goldman Sachs analysis? Cures aren't good business. Symptom mitigation is where it's at.
Monetizing a human by charging them a subscription fee to be who they identify as is a new subscription model that can last a lifetime.
The LTV is huge. The issue is that not many folks identify as trans. If anything, it would be in the interest of Pfizer to encourage more kids to question their identity and transition.